GlassScriptPhysician profile
Lee T Thurber
NPI 1649280611
$1,624.19
in general payments reported to CMS, 2019-2025
16 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.84 · 2020: $565 · 2021: $85.41 · 2022: $239 · 2023: $254 · 2024: $244 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.39 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $500.00 | 2020 | |
| Abbvie INC. | $403.24 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Rayner Intraocular Lenses Limited | $248.56 | 2022-2025 | Omidria, Rayone Spheric, Rayone Aspheric |
| Oyster Point Pharma, INC. | $78.58 | 2022-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $75.74 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $64.58 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $61.29 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $33.27 | 2020-2021 | |
| Harrow Eye, LLC | $28.89 | 2024 | Iheezo |
| Biotissue Holdings INC. | $23.39 | 2022 | |
| Kala Pharmaceuticals, INC. | $22.73 | 2021 | |
| Allergan, INC. | $20.92 | 2020 | |
| Rxsight INC | $19.37 | 2022 | |
| Thea Pharma INC. | $18.17 | 2022 | |
| Glaxosmithkline, LLC. | $13.66 | 2025 | Blenrep |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Thurber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.